ARTICLE | Company News
Kyorin, Merck deal
August 23, 2004 7:00 AM UTC
The companies extended for three years their 1998 deal to develop antibacterials to treat community-acquired pneumonia (CAP) and nosocomial infections. As extended, Kyorin granted MRK exclusive worldw...